Back
Karyopharm Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
KPTI
Karyopharm Therapeutics, Inc.
Last Price:
$6.91
Seasonality Move:
10%
7 Day Trial
ALL ACCESS PASS
$
7
Karyopharm Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 18.4% based on the past 12 years of stock performance.
-
Karyopharm Therapeutics, Inc. has fallen lower in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Karyopharm Therapeutics, Inc. Stock Undervalued?The current Karyopharm Therapeutics, Inc. [KPTI] share price is $6.94. The Score for KPTI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 18.4% based on the past 12 years of stock performance.
Karyopharm Therapeutics, Inc. Stock Rating
Buy
57
Karyopharm Therapeutics, Inc. (KPTI)
is a Buy
Is Karyopharm Therapeutics, Inc. overpriced?
-
Karyopharm Therapeutics, Inc. has fallen lower in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Karyopharm Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
12.45
52-Week Low:
3.51
Prediction Charts
Market Cap:
118.3M
Price in USD:
6.94
Volume:
580.1K
Beta:
0.82
Technical Analysis
SMA50:
5.95
SMA100:
5.92
SMA200:
5.46
52-Wk Change:
-28.78%
Stock Predictions
-
Is Karyopharm Therapeutics, Inc. stock public?Yes, Karyopharm Therapeutics, Inc. is a publicly traded company.
-
What is the Karyopharm Therapeutics, Inc. stock quote today?The Karyopharm Therapeutics, Inc. stock price is 6.94 USD today.
-
How to buy Karyopharm Therapeutics, Inc. stock online?You can buy Karyopharm Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 5.71 | 5.36 | 5.80 | 5.34 |
| Dec-3 | 5.36 | 5.46 | 5.52 | 5.30 |
| Dec-4 | 5.41 | 5.91 | 6.05 | 5.37 |
| Dec-5 | 5.95 | 5.75 | 5.95 | 5.74 |
| Dec-8 | 5.84 | 5.89 | 6.01 | 5.70 |
| Dec-9 | 5.89 | 6.39 | 6.52 | 5.89 |
| Dec-10 | 6.35 | 6.48 | 6.69 | 6.19 |
| Dec-11 | 6.52 | 7.00 | 7.05 | 6.35 |
| Dec-12 | 7.07 | 6.95 | 7.48 | 6.85 |
| Dec-15 | 6.96 | 6.71 | 7.00 | 6.59 |
| Dec-16 | 6.68 | 6.33 | 6.81 | 6.33 |
| Dec-17 | 6.36 | 6.02 | 6.77 | 5.99 |
| Dec-18 | 6.04 | 6.37 | 6.77 | 6.04 |
| Dec-19 | 6.44 | 6.94 | 7.09 | 6.44 |
Karyopharm Therapeutics, Inc. Earnings
Karyopharm Therapeutics, Inc. Earnings Report: Per Share Karyopharm Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Karyopharm Therapeutics, Inc. Forecast Revenue Growth
Karyopharm Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.81 per share, and an increase next year of $7.17 per share.
* Karyopharm Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.